Amit Bhavsar from University of Alberta and his colleagues have identified a receptor in cells that could be the key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug Cisplatin. They believe that, by inhibiting this receptor, they may be able to reduce or eliminate the toxicity from the drug that causes hearing loss.
Cisplatin is an incredibly effective chemotherapeutic when it comes to treating solid tumors in children, contributing to an 80 percent overall survival rate over five years. Audiologists who work with patients undergoing Cisplatin therapy are all too familiar with the problem; nearly 100 percent of patients who receive higher doses show some degree of permanent hearing loss.
The receptor in question is Toll-like receptor 4 (TLR4), which is involved in the body’s immune response. It is a receptor that your body uses to detect when there is some sort of issue, like an infection. This receptor will turn on, and start producing signals that tell the cell it’s under stress. Unfortunately, in the case of Cisplatin, those signals ultimately lead to the death of the cells responsible for hearing.
The only way to prevent the damage is to stop the signals TLR4 produces that lead to the accumulation of Cisplatin. To confirm the efficacy of inhibiting the TLR4 receptor, Bhavsar and his team examined zebrafish sensory cells, which behave similarly to the hair cells in humans that are damaged by Cisplatin. Bhavsar was able to prove that inhibiting TLR4 led to an inhibition of the damage on the sensory cells.
Reference
Ghazal B, Asna L, Ivan K D, et al. (2021) Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity. EMBO Rep 22: e51280
Recent Posts
Mississippi and Missouri Go Live in ASLP Compact
The Audiology & Speech-Language Pathology Interstate Compact (ASLP-IC) continues to expand, with Mississippi officially going live on November 9, and Missouri following on November 16. With…
Senators Merkley and Gillibrand Introduce Professional Student Degree Act
Senators Jeff Merkley (D-OR) and Kirsten Gillibrand (D-NY) have introduced the Professional Student Degree Act in the Senate, companion legislation to H.R. 6718, introduced in the…
CMS Offers States an Optional Pause on Medicaid Work Requirement Enforcement
On November 13, 2026, CMS announced that states may protect otherwise eligible Medicaid applicants and beneficiaries from work-requirement-related coverage denials through June 30, 2027. The…



